THE PHARMACOLOGIC MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS IN FRAIL OLDER ADULTS IS COMPLICATED BY TWO KEY CONSIDERATIONS: the increased likelihood of comorbidities and the increased likelihood of polypharmacy. This brief review summarizes how these factors may impact treatment choices in this population.